Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
BONAPARTE MEDICAL, INC. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This single matter is assigned to 1 examiner, RESTAINO, ANDREW PETER, within 1 distinct art unit. This indicates a very specific and singular focus for the company's current patent prosecution.
The busiest examiner, RESTAINO, ANDREW PETER, is responsible for the 1 pending office action, making him the sole official currently reviewing the company's pending work. Because there is only 1 distinct art unit involved, the prosecution is subject to the specific standards and procedures of that single group. The 1 to 1 ratio of pending office actions to examiners means that the company's success at the patent office is currently tied to this one interaction.
Practitioners should focus on the specific requirements of the 1 distinct art unit and the examiner's past decisions to navigate this single pending office action. This lack of diversity in examiners or art units simplifies the administrative task but increases the importance of this single case's outcome. For a company in the Medical Devices & Mechanical Engineering sector, this single action represents the entirety of their current engagement with the patent office. Success depends on navigating the specific standards of the 1 distinct art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RESTAINO, ANDREW PETER | 1 | 72.4% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19211676 | Percutaneous Cardiac Tissue Cutter | RESTAINO, ANDREW PETER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19211676 | Percutaneous Cardiac Tissue Cutter | RESTAINO, ANDREW PETER | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19211676 | Percutaneous Cardiac Tissue Cutter | RESTAINO, ANDREW PETER | 3771 | §102§103§112 | Non-Final OA | — | Pending | May 19, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBONAPARTE MEDICAL, INC. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Andrew Peter Restaino has the most, with 1 of BONAPARTE MEDICAL, INC.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
